Cargando…
Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor
BACKGROUND AND AIMS: Treatment of colorectal adenomas with selective cyclooxygenase-2 inhibitors can contribute to the chemoprevention of colorectal cancer (CRC), but the molecular background of their effect is not fully understood. We analysed the gene expression modulatory effect of N-(2-cyclohexy...
Autores principales: | Galamb, O, Spisák, S, Sipos, F, Tóth, K, Solymosi, N, Wichmann, B, Krenács, T, Valcz, G, Tulassay, Z, Molnár, B |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837560/ https://www.ncbi.nlm.nih.gov/pubmed/20087348 http://dx.doi.org/10.1038/sj.bjc.6605515 |
Ejemplares similares
-
Potential Biomarkers of Colorectal Adenoma–Dysplasia–Carcinoma Progression: mRNA Expression Profiling and In Situ Protein Detection on TMAs Reveal 15 Sequentially Upregulated and 2 Downregulated Genes
por: Galamb, Orsolya, et al.
Publicado: (2009) -
Applicability of Antibody and mRNA Expression Microarrays for Identifying Diagnostic and Progression Markers of Early and Late Stage Colorectal Cancer
por: Spisák, Sándor, et al.
Publicado: (2010) -
Dysplasia-Carcinoma Transition Specific Transcripts in Colonic Biopsy Samples
por: Galamb, Orsolya, et al.
Publicado: (2012) -
Sporadic Colorectal Cancer Development Shows Rejuvenescence Regarding Epithelial Proliferation and Apoptosis
por: Leiszter, Katalin, et al.
Publicado: (2013) -
Promoter Hypermethylation-Related Reduced Somatostatin Production Promotes Uncontrolled Cell Proliferation in Colorectal Cancer
por: Leiszter, Katalin, et al.
Publicado: (2015)